Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials
This systematic review and meta-analysis substantiate the claim that psilocybin is superior in treating depression compared to established psychotherapy alone used for treating depression. This finding warrants further studies with larger sample sizes and across a longer timeframe.
Authors
- Omid Kohandel Gargari (ORCID: https://orcid.org/0000-0002-8182-0582)
- Ida Mohammadi (ORCID: https://orcid.org/0000-0002-0662-0329)
- Kyana Jafarabady
- Touran Bahrami Babaheidari (ORCID: https://orcid.org/0000-0002-8516-5597)
- Aida Rezaei Nejad (ORCID: https://orcid.org/0000-0001-7737-7824)
- Arman Shafiee (ORCID: https://orcid.org/0000-0002-1941-4399)
- Mahmood Bakhtiyari
- Sepehr Aghajanian (ORCID: https://orcid.org/0000-0001-6062-0138)
- Shahryar Rajai Firouzabadi (ORCID: https://orcid.org/0000-0001-6511-4103)
- Samira Parvizi Omran
Institutions
- Jahrom University of Medical Sciences (IR)
- Alborz University of Medical Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1177/02698811241287542
- Citations
- 11
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 7.03